Sensus Healthcare Inc (SRTS)
7.64
+0.35
(+4.80%)
USD |
NASDAQ |
Nov 15, 16:00
7.68
+0.04
(+0.52%)
After-Hours: 20:00
Sensus Healthcare Research and Development Expense (TTM): 3.552M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 3.552M |
| March 31, 2024 | 3.508M |
| December 31, 2023 | 3.68M |
| September 30, 2023 | 4.161M |
| June 30, 2023 | 3.824M |
| March 31, 2023 | 3.829M |
| December 31, 2022 | 3.459M |
| September 30, 2022 | 3.407M |
| June 30, 2022 | 3.405M |
| March 31, 2022 | 3.503M |
| December 31, 2021 | 3.436M |
| September 30, 2021 | 3.173M |
| June 30, 2021 | 3.37M |
| March 31, 2021 | 3.593M |
| December 31, 2020 | 4.157M |
| September 30, 2020 | 4.264M |
| June 30, 2020 | 4.890M |
| March 31, 2020 | 5.677M |
| Date | Value |
|---|---|
| December 31, 2019 | 6.418M |
| September 30, 2019 | 6.953M |
| June 30, 2019 | 7.098M |
| March 31, 2019 | 6.728M |
| December 31, 2018 | 6.260M |
| September 30, 2018 | 6.471M |
| June 30, 2018 | 6.259M |
| March 31, 2018 | 5.853M |
| December 31, 2017 | 5.491M |
| September 30, 2017 | 4.523M |
| June 30, 2017 | 3.412M |
| March 31, 2017 | 2.666M |
| December 31, 2016 | 1.824M |
| September 30, 2016 | 1.431M |
| June 30, 2016 | 1.400M |
| March 31, 2016 | 1.320M |
| December 31, 2015 | 1.467M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
3.173M
Minimum
Sep 2021
6.418M
Maximum
Dec 2019
3.964M
Average
3.593M
Median
Mar 2021
Research and Development Expense (TTM) Benchmarks
| Perspective Therapeutics Inc | 28.53M |
| Retractable Technologies Inc | 0.654M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 2.145M |
| Catheter Precision Inc | 0.219M |